Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 2041 AL 2055

5-HT(2A) receptors and Parkinson's disease psychosis: a pharmacological discussion

Huot P.

Neurodegener Dis Manag. 2018 Dec;8(6):363-365. doi: 10.2217/nmt-2018-0039. Epub 2018 Nov 19.

Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease

Sanjari Moghaddam H, Aarabi MH.

Mov Disord. 2018 Dec;33(12):1876. doi: 10.1002/mds.27509. Epub 2018 Nov 19.

Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci

Tang S, Yao B, Li N, Lin S, Huang Z.

Cell Physiol Biochem. 2018;51(1):411-428. doi: 10.1159/000495238. Epub 2018 Nov 19.

Home-based Combined Therapy with Rehabilitation and Aggressive Nutrition Management for a Parkinson's Disease Patient with Sarcopenic Dysphagia: A Case Report

Yamada Y, Shamoto H, Maeda K, Wakabayashi H.

Prog Rehabil Med. 2018 Nov 20;3:20180019. doi: 10.2490/prm.20180019. eCollection 2018.

Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson's disease (PD)

Zhou ZD, Lee JCT, Tan EK.

Mutat Res Rev Mutat Res. 2018 Oct-Dec;778:72-78. doi: 10.1016/j.mrrev.2018.10.001. Epub 2018 Oct 17.

Risk Stratification of an Accessory Pathway Using Isoproterenol after Cardiac Arrest

Burstein B, Barbosa R, Larochelle MP, Samuel M, Essebag V, Bernier ML.

J Atr Fibrillation. 2018 Jun 30;11(1):2054. doi: 10.4022/jafib.2054. eCollection 2018 Jun-Jul.

[Optical Coherence Tomography in Disorders of the Central Nervous System]

Papadopoulou A, Oertel FC, Zimmermann H, Zeitz O, Brandt AU, Paul F.

Klin Monbl Augenheilkd. 2018 Nov;235(11):1242-1258. doi: 10.1055/a-0715-7961. Epub 2018 Nov 20.

Thermoregulation in Parkinson disease

Coon EA, Low PA.

Handb Clin Neurol. 2018;157:715-725. doi: 10.1016/B978-0-444-64074-1.00043-4.

Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson's Disease and Synucleinopathies

Betzer C, Jensen PH.

Front Neurosci. 2018 Nov 6;12:819. doi: 10.3389/fnins.2018.00819. eCollection 2018.

Neuromodulatory Effects of Guanine-Based Purines in Health and Disease

Tasca CI, Lanznaster D, Oliveira KA, Fernández-Dueñas V, Ciruela F.

Front Cell Neurosci. 2018 Oct 23;12:376. doi: 10.3389/fncel.2018.00376. eCollection 2018.

Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

Troncoso-Escudero P, Parra A, Nassif M, Vidal RL.

Front Neurol. 2018 Oct 15;9:860. doi: 10.3389/fneur.2018.00860. eCollection 2018.

Is Transposition of Deep Brain Stimulation Device a Solution in Patients with Recurrent Skin Erosions?

Servello D, Saleh C, Zekaj E.

Asian J Neurosurg. 2018 Oct-Dec;13(4):1252-1253. doi: 10.4103/ajns.AJNS_184_17.

The feasibility, acceptability and outcomes of exergaming among individuals with cancer: a systematic review

Tough D, Robinson J, Gowling S, Raby P, Dixon J, Harrison SL.

BMC Cancer. 2018 Nov 21;18(1):1151. doi: 10.1186/s12885-018-5068-0.

Systematic Review: Online Crowdsourcing to Assess Perceptual Speech Outcomes

Sescleifer AM, Francoisse CA, Lin AY.

J Surg Res. 2018 Dec;232:351-364. doi: 10.1016/j.jss.2018.06.032. Epub 2018 Jul 18.

Profile of inhaled levodopa and its potential in the treatment of Parkinson's disease: evidence to date

Patel AB, Jimenez-Shahed J.

Neuropsychiatr Dis Treat. 2018 Nov 2;14:2955-2964. doi: 10.2147/NDT.S147633. eCollection 2018.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias